Funding, licensing, and partnerships are the lifeblood for the Life Science industry. New sources of funding are critical to the continuing development of your programs and will determine your exit strategy. That is nothing new or surprising. Success or failure is a function of how well you’re organized; how well you manage that information; and how easy it is for others to review your critical documents.
As everyone knows, the due diligence process will be a thorough, painful vetting of everything and everyone in your business. However, it is necessary and paramount in establishing the value and price of any investment or partnership. Your team will have to pull together and provide exhaustive information on the nature and scope of your business. Critical items, such as, IP rights, know-how, proprietary technology, and employee leadership capabilities will have to be properly documented to reduce risk and increase the value of any investment.